Navigation Links
Support at Fever Pitch for Dynamic, Fresh Approach to Pharmaceutical Competitive Intelligence
Date:3/25/2009

PARSIPPANY, N.J., March 25 /PRNewswire/ -- It's a different era for pharmaceutical companies trying to remain on the forefront of an ever-changing industry while battling an uncertain economy. Now, more than ever, pharmaceutical competitive intelligence is the key to retaining market share and maintaining hard-earned industry relevancy. All decision makers need the powerful tools of pharmaceutical competitive intelligence.

The Pharma CI Conference & Exhibition is the industry's gold standard for senior level pharma, biotech, medical device, and diagnostics professionals who seek the latest in competitive intelligence/business intelligence. Last year's event sold out in record time! People packed rooms beyond capacity! And 2009 is on track for another banner year. Anticipation is growing for the 2009 Pharma CI Conference on September 15-16th; it's hands-down the premier event for networking with the industry's luminaries, and gaining insight from cutting edge speakers who are ahead of the curve.

The Pharma CI Conference delivers a fresh approach to addressing complex issues. There are 40+ different sessions planned to customize participation. Some of the topics include the following:

  • The Biopharmaceutical Industry Can Adapt To Change For A Brighter Future
  • Customized Healthcare in a Comparative Effectiveness World
  • Developing a Counter-Intelligence System
  • Follow-on Biologics: Political Landscape and Key Provisions
  • Managed Markets, Formularies & You: The Use of Competitive Intelligence to Understand the Most Influential Growth Sales and Marketing Category
  • Future and Competitor Proofing Your Strategy
  • Leveraging CI to Optimize Late Lifecycle Strategic Planning
  • And many more...

The expert speaking faculty consists of 60+ senior level executives from these world-class companies: APP Pharmaceuticals, ArthroCare, Astellas, Baxter Corporation, Bayer Healthcare, Biovail, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Depuy Spine (J&J), DSM Pharmaceuticals, Dyax Corporation, Eisai, Ethicon, a Johnson& Johnson Company, Exelixis, Gen-Probe, Genentech, General Electric, Genzyme, GlaxoSmithKline, Lifescan, Medtronic, Merck, Millennium Pharmaceuticals, Nicox, Novartis, Pfizer, Roche Diagnostics, Sanofi-Aventis, Smith & Nephew, Thermo Fisher Scientific, Vertex, and Wyeth.

A preliminary listing of sponsors/exhibitors include the following companies: Best Practices, BioMedTracker, Bioxcel, Deallus, Digimind, Dolcera, Dunn Group, Fletcher/CSI, Fuld & Company, Indegene, InfoNgen, I.S.I.S., Inc., Lifescience Dynamics, MedPredict, PharmaForce, Pharmavoxx, and Sedulo Group.

The Pharma CI Conference & Exhibition will be held September 15-16, 2009 at the Sheraton Parsippany Hotel, New Jersey. For more information, or to register, go to www.Pharmaciconference.com. You can also call 212.228.7974 or email info@pharmaciconference.com.


'/>"/>
SOURCE The Pharma CI Conference & Exhibition
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HIV therapy in pregnancy-data support WHO recommendations
2. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
3. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
4. Family-based treatment more effective than supportive psychotherapy in treating bulimia
5. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
6. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
7. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
8. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
9. Hundreds of MADD Supporters Meet in St. Louis on Sept. 6-8
10. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
11. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Miami Dental ... implants to their Miami dental office. Beginning in January, Miami Dental Specialists will ... Miami Dental Specialists are the first office to be chosen by the dental implant ...
(Date:2/12/2016)... ... February 12, 2016 , ... Atlantic Information Services, ... Plans and PBMs,” an upcoming Feb. 24 webinar that will discuss ways health ... therapeutic categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... The Central Coast Autism Spectrum Center (CCASC) ... is to provide a night of fun for teens with and without special needs to ... welcomed and included at the event. The dance will take place on Saturday, Feb. 13 ...
(Date:2/12/2016)... CA (PRWEB) , ... February 12, 2016 , ... With the exception of restorative dentistry, ... of dental decay. With the recent approval by the FDA, there is a now ... similar to fluoride varnish, SDF is very simple and quick to apply. The application ...
(Date:2/11/2016)... ... February 11, 2016 , ... SPH Analytics ... action analytics leader’s population health solutions, MDinsight® and IndiGO®, for its primary care ... healthcare system. Details of the contract were not disclosed. , As the healthcare ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Feb. 12, 2016  SI-BONE, Inc., a medical device company ... ("iFuse"), a minimally invasive surgical (MIS) device indicated for fusion for ... Services, Inc. (NGS), the Medicare Administrative Contractor (MAC) covering the states ... Maine , Massachusetts , ... New York , Rhode Island , ...
(Date:2/12/2016)... and SEOUL, South Korea ... Menarini and Macrogen, Inc. today announced they will ... innovative procedures for precision medicine in cancer. The ... Biosystems, DEPArray™ digital-sorting technology with Macrogen,s high-throughput Next ... certified under the Clinical Laboratory Improvement Amendments (CLIA) ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis ... completed a $47.1 million Series D preferred ... Asset Management, Hillhouse Capital Group and venBio ... Venture Investments, AJU IB Investment, and Epidarex ... used to further advance clinical trials in ...
Breaking Medicine Technology: